BHCM
DMRA

Brevan Howard Capital Management’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Brevan Howard Capital Management’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.43M Buy
+55,232
New +$1.42M 0.01% 717

Other funds holding DMRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $281M AUM

Brevan Howard Capital Management's DMRA Position: Q1 2026 in Review

Brevan Howard Capital Management opened a new position in Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q1 2026: 55,232 shares worth $1.43M. The stake represents 0.01% of the portfolio and ranks #717 among its holdings.

65 funds tracked by Wall St. Rank hold DMRA as of Q1 2026.

  • Brevan Howard Capital Management held 55,232 shares of Damora Therapeutics, Inc. Ordinary Shares worth $1.43M as of Q1 2026.
  • Damora Therapeutics, Inc. Ordinary Shares was a new Brevan Howard Capital Management position in Q1 2026.
  • Damora Therapeutics, Inc. Ordinary Shares made up 0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #717 holding.
  • 65 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.